World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 11 February 2019
Main ID:  ISRCTN23704397
Date of registration: 02/07/2014
Prospective Registration: No
Primary sponsor: County Council of Västerbotten (Sweden)
Public title: Could treatment with prolonged peripheral nerve block reduce phantom limb pain on lower extremity amputation?
Scientific title: Could treatment with prolonged peripheral nerve block reduce phantom limb pain on lower extremity amputation? A randomized controlled study
Date of first enrolment: 19/05/2014
Target sample size: 60
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN23704397
Study type:  Interventional
Study design:  Randomized controlled trial (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Sweden
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Anna    Unneby
Address:  Umeå University Hospital Department of Orthopedics 901 85 Umeå Sweden
Telephone: -
Email: unneby85@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Age 65 years or older
2. With a decision from the responsible orthopedic physician that a transtibial amputation of one or both legs is necessary
3. Residents to the county of Norrland University Hospital

Exclusion criteria: Younger than age 65

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Transtibial amputation of one or both legs, phantom limb pain
Musculoskeletal Diseases
Intervention(s)

Once the doctor has decided on amputation he/she will contact the research nurse, which in turn will provide written and verbal information about the study to the patient for approval of participation. Then the patient is randomized to a treatment group by drawing lots. A non-transparent envelope is opened containing information about the study and consent forms to be signed. A person who is not included in the study mixes the envelopes with the two treatment options, then placed them in a single junction of the department where the study will be conducted. The person who gives the information to the patient takes the top envelope in the pile.

1. The intervention group receives a peripheral nerve block of the ischiadic nerve by placing a catheter just above the back of the knee using ultrasound adjacent with the ischiadic nerve. This is done in conjunction with the amputation. Postoperatively local anesthetic of Chirocaine 2.5 mg / ml, 20 ml is administered as bolus into the catheter at intervals of 4-6 hours/day. Treatment with peripheral nerve blockade continues until the patient is discharged.
2. The control group receive EDA (epidural) pain management which is currently the usual pain treatment for amputations.
Primary Outcome(s)

1. Phantom pain
2. Phantom sensation
Measured from the day of surgery (six times a day, for at least 1 week), from day 7 until discharge 3 times a day and at 3, 6 and 12 months.
Secondary Outcome(s)

1. Quality of life
2. Subjected well-being [Philadelphia Geriatric Center Morale Scale (PGCMS)]
3. Depression [15-item Geriatric Depression Scale (GDS-15)]
Measured from the day of surgery (six times a day, for at least 1 week), from day 7 until discharge 3 times a day and at 3, 6 and 12 months.
Secondary ID(s)
N/A
Source(s) of Monetary Support
County Council of Västerbotten (Sweden), Dementia Foundation (Sweden)
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Ethical Committee of the Faculty of Medicine at Umeå University, 23/01/2014, ref: 2013-413-31M
Results
Results available: Yes
Date Posted:
Date Completed: 01/06/2017
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history